TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Intravenous Catheter Application and Fluid Delivery Skills Checklist scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depressive status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse reactions reported
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of spontaneous abortion, stillbirth, or neonatal death
Endpoint domain: Adverse events/effects
Primary endpoint: RCB 0 or 1 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SARS-CoV-2 neutralization titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C3a levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clotting times (aPTT, PT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SAER (Severe Asthma Exacerbation Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: fitness total points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of thigh pain
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of stress shielding
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative best-corrected visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of ocular hypertension
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of epiretinal membrane (ERM)
Endpoint domain: Adverse events/effects
Primary endpoint: Normal spermiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: First-pass success rate of spinal needle placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 72-h ΔSOFA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidents of hypernatremia
Endpoint domain: Adverse events/effects
Primary endpoint: relative hyperopia in the temporal retina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: myopia control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: breast pain
Endpoint domain: Adverse events/effects
Primary endpoint: breast edema
Endpoint domain: Adverse events/effects
Primary endpoint: PASI75 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sPGA 0/1 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to PASI75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year risk of incident diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurements achieving QF A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPAD value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grain yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KCCQ-TSS improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in cardiovascular death/worsening HF
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in the number of nightmares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mandibular length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower facial height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AKS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No complications related to the operation
Endpoint domain: Adverse events/effects
Primary endpoint: mean number of days until occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cooperativeness with anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with nursing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peripheral glucose disposal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motor performance difference
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: adherence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hair growth improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binge-eating episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tic severity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in total fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decrease in DHEA-S
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: CV death or heart failure hospitalisations
Endpoint domain: Mortality/survival
Primary endpoint: renal-specific composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Students' apprehension of knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recall of key aspects of informed consent
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Satisfaction with the informed consent process
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: LMUP score of 10+
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cl- load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increase in Systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in Diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in isovo-lumic relaxation time (IVRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of organ support-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restrained eating behaviours
Endpoint domain: Life impact
Endpoint subdomain: Eating attitudes
Primary endpoint: Poorer body image
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level (QVAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function (K-ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transverse abdominis muscle thickness in contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of Life (QoL) decrement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of moderate/severe symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: All-cause grade ≥ 3 treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cutaneous sensory blockade area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first fetal cardiac acceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first fetal movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly heartburn severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly regurgitation frequency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSIQ scores at 5 years of age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Seroconversion rate of SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time with levels below range (<70 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to protein-adjusted 90% inhibitory concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median predicted infant dolutegravir half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yo-Yo IR1 distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective ratings of mental fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Soccer-specific technical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: kidney-specific composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Financial distress
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Employment impacts
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Normal Tissue Complication Probability (NTCP) differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment percentage in model-based trials
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: exercise compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time in range 70-180 mg/dL (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: less perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ease of management (user scoring system)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcomes on prazosin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in belief in misinformation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in knowledge about typhoid risk reduction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-reported increase in drinking treated water
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Cortical reactivity to TMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: m-AHEI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of anaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of thrombocytopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of liver abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: rate of residual cancer burden class 0-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of participants achieving at least 10% weight reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AF load and recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: International Hip Outcome Tool 12 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nonarthritic Hip Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neurosensory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-craniectomy headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain control (visual analog scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TFV AUC6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glycerol mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Predicted terminal half-life values for delamanid and DM-6705
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain tissue oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GPE scale difference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative total pethidine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monthly average number of migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monthly days of acute medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine Disability Assessment scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum plasma concentration (Cmax) of midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) of midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of lusutrombopag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) of lusutrombopag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder ROM limitations reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol and cannabis use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAE rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first CAE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung function (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean MBR values at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean MBR values at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean diurnal intraocular pressure (IOP) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean diurnal outflow facility change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean diurnal episcleral venous pressure (EVP) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Annual pure red cell requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: OSDI (Ocular Surface Disease Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: OXFORD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: symmetry of maxillary expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stability of area and volume of the palatine vault
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal IKDC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instrumented knee laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pivot shift normality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreasing complications
Endpoint domain: Adverse events/effects
Primary endpoint: improving postoperative recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual incidence of brucellosis
Endpoint domain: Mortality/survival
Primary endpoint: maximal Hb drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimated blood loss (EBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MGH-SFI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: HAMD-17 item 14 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA-UE score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WMFT score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBI score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in skin texture and atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scar volume improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Postinflammatory hyperpigmentation (PIH) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: non-inferiority of novel SCB to conventional PCB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative satisfaction rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in pain during activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deactivation of MTrPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability related to pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity for detecting feigned symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ANCSA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of involuntary body movements
Endpoint domain: Adverse events/effects
Primary endpoint: reported close contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quantity of person descriptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: utility of descriptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family caregivers' perceived burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Three-year BCRFS
Endpoint domain: Mortality/survival
Primary endpoint: CPFS
Endpoint domain: Mortality/survival
Primary endpoint: Patient-reported outcomes of urinary symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EORTC‐QLQ‐C30 General Health scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: units of PRBCs transfused
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Development of fine motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance in predicting ER
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hyperarousal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in avoidance symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infection with VRC01-sensitive isolates
Endpoint domain: Mortality/survival
Primary endpoint: Health assessment by dietitians
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased satisfaction with life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in intrusive/avoidant thoughts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prognostic benefit of revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic tool efficacy of coronary CTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bioequivalence of MSB11022 delivery methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for reexcision
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: serum levels of indoxyl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: breathing pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 30-second chair stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical domain of QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: accuracy in linking words to referents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy in encoding semantic categories for words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy in encoding detailed representations of word forms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induction of exosomal hsa-miR-32-5p and hsa-miR-29b-3p
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinicians' progress assessment accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of making a treatment change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes